Market Inference Overview — AGL Stock

Agilon health inc. logged a -3.0% change Friday, and is now trading at a price of $15.39 per share. The S&P 500 index moved 2.3% and the Nasdaq posted a 2.8% change. AGL's trading volume was 1,520,786 compared to the stock's average volume of 1,768,395.

Agilon shares have moved -31.3% over the last 52 weeks, with a high of $28.36 and a low of $14.36. During this time, the stock lagged the S&P 500 index by -14.7%. As of January 2022, the company's 50-day average price is $17.4814. Agilon offers healthcare services for seniors through primary care physicians in the communities of the United States. The large-cap Healthcare company has 646 full time employees and is based in Austin, TX. Agilon has not offered any dividends in the last year.

Declining EPS Growth and Lack of Profitability:

2019-12-31 2020-12-31 2021-12-31
Revenue (MM) $794 $1,218 $1,834
Revenue Growth n/a 53.36% 50.5%
Gross Margins 3.6% 7.7% 4.2%
Gross Margins Growth n/a 113.89% -45.45%
Operating Margins -13.4% -4.6% -21.5%
Operating Margins Growth n/a 65.67% -367.39%
Earnings Per Share -$0.74 -$0.16 -$1.09
EPS Growth n/a 78.38% -581.25%
Free Cash Flow (MM) -$108 -$56 -$162
FCF Growth n/a 48.45% -190.86%
Capital Expenditures (MM) -$4 -$2 -$13
Net Debt / EBITDA 0.83 0.97 2.58

Agilon Is Overvalued:

Compared to the Healthcare sector's average of 13.21, agilon health inc. has a trailing twelve month price to earnings (P/E) ratio of -15.4 and, based on its EPS guidance of -0.01, an expected P/E ratio of -1539.0.

Agilon health inc.'s price to book (P/B) ratio is 5.8 compared to its sector average of 4.07. The company is likely overvalued in terms of its equity.

agilon health inc. Is the Subject of Mixed Market Indicators:

14 analysts are following Agilon health inc. and have set target prices ranging from $22 to $41 per share. On average, they have given the company a rating of buy. At the current price of $15.39, AGL is trading -45.92% away from its average analyst target price of $28.46 per share, implying an analyst consensus of strong upside potential for the stock.

The company has an unusually large proportion of its shares sold short since 15.6% of the company's shares are tied to short positions. Institutions own 103.2% of Agilon health inc.'s shares, while the insider ownership rate stands at 1.12%. The biggest shareholder is Clayton, Dubilier & Rice, LLC with a 47% stake in the company worth approximately $2,995,068,096.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.